Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

What's In The Cards For Centene's (CNC) Earnings In Q4?

Published 01/30/2020, 10:51 PM
Updated 07/09/2023, 06:31 AM

Centene Corporation (NYSE:CNC) will release fourth-quarter 2019 results on Feb 4, before the market opens.

For the to-be reported quarter, we expect to see an increase in revenues and membership. Let’s see how things are shaping up prior to this announcement.
For the to-be-reported quarter, the Zacks Consensus Estimate for its bottom line is pegged at 74 cents, indicating an increase of 7.2% from the year-ago reported figure.

The company’s fourth-quarter performance is likely to have been supported by its solid Government and Medicaid businesses. However, revenues are expected to have been partially offset by state-directed payments previously mentioned.

The consensus mark for the company’s top line suggests an upside of 11.6% from the year-earlier reported figure. Other factors, such as higher membership might also have provided a cushion to the revenue base.

The company’s upcoming quarterly results are likely to reflect growth in its Marketplace business. It is expected to have gained members on the back of several contract wins and new programs. The Zacks Consensus Estimate for the company's total membership count implies a rise of 6% from the prior-year reported number.

The quarter to be reported is likely to have witnessed higher premiums. The consensus estimate for the same hints at 13.3% growth from the year-ago reported figure.

The Zacks Consensus Estimate for fourth-quarter general and administrative expense ratio is pegged at 9.45%, suggesting a decline from 9.90% in the same period last year.

However, interest expenses of the company are anticipated to have escalated persistently.

What the Quantitative Model States

Our proven model does not conclusively predict an earnings beat for Centene this reporting cycle. The right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of a positive surprise, which is not the case here. You can see the complete list of today’s Zacks #1 Rank stocks here.

Earnings ESP: Centene has an Earnings ESP of -2.26%. This is because the Most Accurate Estimate is pegged at 72 cents, lower than the Zacks Consensus Estimate of 74 cents. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Centene Corporation Price and EPS Surprise

Centene Corporation price-eps-surprise | Centene Corporation Quote

Zacks Rank: Centene carries a Zacks Rank #3, which increases the predictive power of ESP. However, the company’s negative ESP in the combination leaves surprise prediction inconclusive for the stock this earnings season.

Highlights of Q3 Earnings and Surprise History

Centene delivered third-quarter 2019 adjusted earnings per share of 96 cents, beating the Zacks Consensus Estimate by 1.1%. Also, the bottom line improved 5.6% year over year on the back of higher revenues.

The company boasts a stellar earnings record, having delivered a positive surprise in all the trailing four quarters, the average being 4.5%.

Stocks to Consider

Here are a few stocks worth considering with the perfect mix of elements to beat on earnings in the respective upcoming releases:

Encompass Health Corporation (NYSE:EHC) is slated to report fourth-quarter earnings on Feb 26. It has a Zacks Rank of 3 and an Earnings ESP of +3.57%.

Molina Healthcare, Inc (NYSE:MOH) is set to report fourth-quarter earnings on Feb 10. The company is Zacks #3 Ranked and has an Earnings ESP of +0.38%.

Teladoc Health, Inc. (NYSE:TDOC) is slated to announce fourth-quarter earnings on Feb 26. The stock has an Earnings ESP of +9.38% and is a #3 Ranked player.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.

This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.

See their latest picks free >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Centene Corporation (CNC): Free Stock Analysis Report

Molina Healthcare, Inc (MOH): Free Stock Analysis Report

Teladoc Health, Inc. (TDOC): Free Stock Analysis Report

Encompass Health Corporation (EHC): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.